Xylem (NYSE: XYL ) is expected to report Q2 earnings on July 30. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Xylem's revenues will grow 0.2% and EPS will wane -8.2%.
The average estimate for revenue is $967.9 million. On the bottom line, the average EPS estimate is $0.45.
Last quarter, Xylem chalked up revenue of $879.0 million. GAAP reported sales were 5.0% lower than the prior-year quarter's $925.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.27. GAAP EPS of $0.22 for Q1 were 35% lower than the prior-year quarter's $0.34 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 38.0%, 120 basis points worse than the prior-year quarter. Operating margin was 8.2%, 300 basis points worse than the prior-year quarter. Net margin was 4.7%, 210 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $3.87 billion. The average EPS estimate is $1.82.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 81 members out of 85 rating the stock outperform, and four members rating it underperform. Among 27 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 26 give Xylem a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Xylem is outperform, with an average price target of $30.58.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Xylem to My Watchlist.